Treating modifiable cardiovascular risk factors, particularly hypertension, is important for mitigating cognitive decline in older patients with mild cognitive impairment and a history of major depressive disorder.
Supports hypertension control to slow cognitive decline in MCI with depression; hypothesis-generating pending RCTs.
This study reinforces the importance of treating modifiable CVRFs, specifically hypertension, as a means of mitigating cognitive decline in patients with at-risk cognitive conditions.
No takes yet. Share an insight, caveat, or question.
Karameh et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: